Abbott Laboratories (ABT) Ownership Increased by Ubs Asset Management Americas Inc

Sergio Conner
November 14, 2017

North Star Asset Management Inc acquired 8,730 shares as Abbott Labs (ABT)'s stock declined 3.42%. Longfellow Investment Ltd Liability Co holds 0.51% or 44,376 shares. Abbott Laboratories now has a P/E ratio of 45.21 and market capitalization is 95.45B. The stock price recently experienced a 5-day loss of -1.21% with 0.75 average true range (ATR). Moreover, Rk Asset Management Llc has 3.72% invested in the company for 261,448 shares.

Mackenzie Financial Corp decreased its stake in Abbott Labs (ABT) by 96.5% based on its latest 2017Q2 regulatory filing with the SEC. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The company had revenue of $6.83 billion during the quarter, compared to the consensus estimate of $6.72 billion.

In the market the company is trading down from yesterday's close of 55.3. About 175 shares traded.

Boston Financial Mangement LLC lowered its stake in Abbott Laboratories (NYSE:ABT) by 59.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. It has underperformed by 0.80% the S&P500.

Abbott Laboratories (NYSE:ABT) last posted its earnings results on Wednesday, October 19th.

China Oct factory output growth slows, retail sales miss expectations
One of the main pieces of the data provided was the stellar industrial output which increased by 6.2% from a year ago. China's economy slowed further in October with economists eyeing scope for further cooling ahead.

Chelsea legend Didier Drogba to retire at end of season
I need to have time for my other projects. " It's good to play, but at 39, it holds me back a bit ", he added. The 39-year-old Ivory Coast superstar has been playing for American side Phoenix Rising, who play in the USL.

No Xbox One X Bundles will be released this holiday season
Dell's Alienware 17 laptop is available for $1,600, but again, doesn't list the original price. More information will be available when Dell's Black Friday sales begin on November 15.

For the current quarter, 17 analysts are projecting a mean EPS of $0.73/share. ABT's profit will be $1.27B for 18.77 P/E if the $0.73 EPS becomes a reality. During the same quarter in the prior year, the business posted $0.54 EPS. It also reduced General Electric (NYSE:GE) stake by 13,399 shares and now owns 306,707 shares. It dived, as 69 investors sold ABT shares while 545 reduced holdings. Zacks Investment Research upgraded shares of Abbott Laboratories from a "hold" rating to a "buy" rating and set a $47.00 target price for the company in a report on Tuesday, September 20th. Therefore 64% are positive. Arcelormittal had 49 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Credit Suisse on Wednesday, August 30 with "Outperform". On October 19, 2017 BMO Capital Markets reiterated a "Market Perform" rating on the stock. The firm has "Neutral" rating given on Friday, November 13 by Goldman Sachs. The stock of Abbott Laboratories (NYSE:ABT) earned "Outperform" rating by RBC Capital Markets on Friday, January 29. The firm has "Hold" rating by Stifel Nicolaus given on Friday, July 14. Jefferies Group reduced their target price on shares of Abbott Laboratories from $52.00 to $48.00 and set a "buy" rating for the company in a report on Tuesday, September 13th.

Since June 15, 2017, it had 0 insider purchases, and 1 sale for $26,482 activity. Year to Date (YTD) performance of Abbott Laboratories (ABT) is 43.97 percent while its Performance (Week) is 0.53 percent and Performance (month) is at 1.19 percent. 79 funds opened positions while 220 raised stakes. Sather Fin Gp owns 5,450 shares for 0.1% of their portfolio. Coastline reported 20,512 shares. (NYSE:MRK). Croft has 3,752 shares for 0.06% of their portfolio. State Street invested in 0.33% or 76.96 million shares. Partner Investment Limited Partnership holds 0.78% in Spectranetics Corp (NASDAQ:SPNC) or 15,056 shares. National Planning invested in 0.1% or 26,732 shares. Bank of New York Mellon Corp grew its stake in shares of Abbott Laboratories by 11.0% in the first quarter. V Wealth Management LLC bought a new position in shares of Abbott Laboratories during the second quarter worth about $127,000. Legacy Prtnrs holds 1.72% or 65,272 shares. Weybosset Research Mgmt Ltd Liability accumulated 4,700 shares or 0.15% of the stock. Scotia Capital stated it has 257,865 shares. 98,337 are held by Wealthtrust Fairport Limited Liability Co.

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: Seekingalpha.com which released: "Abbott's Inviting New Allure" on October 27, 2017, also Seekingalpha.com with their article: "Abbott Laboratories: Quality Deserves A Price, Just Not This Price" published on October 20, 2017, Investorplace.com published: "Abbott Laboratories' (ABT) High-Level Sales Growth Make it a Buy" on November 07, 2017. Eight investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. Therefore 28% are positive. Pentair Inc. had 72 analyst reports since July 22, 2015 according to SRatingsIntel. Cowen & Co maintained it with "Buy" rating and $68.0 target in Wednesday, October 18 report. The firm has "Buy" rating by Jefferies given on Monday, December 7. The firm earned "Neutral" rating on Tuesday, November 22 by Moffett Nathanson. As per Friday, February 5, the company rating was upgraded by Argus Research. The rating was maintained by Stifel Nicolaus with "Buy" on Thursday, July 23. The rating was reinitiated by Jefferies on Thursday, June 29 with "Buy". (NYSE:PNR), 8 have Buy rating, 3 Sell and 12 Hold. As per Monday, July 10, the company rating was downgraded by UBS. HOGAN RANDALL J sold $14.53 million worth of stock. 444.27 million shares or 0.66% less from 447.23 million shares in 2017Q1 were reported.

Investors sentiment increased to 1 in 2017 Q2. Its down 0.75, from 1.63 in 2017Q1. 41 funds opened positions while 138 raised stakes. Bruce & has 2.56% invested in Abbott Laboratories (NYSE:ABT) for 230,915 shares. Schwab Charles Investment Mngmt holds 0.09% of its portfolio in Zoetis Inc (NYSE:ZTS) for 1.60M shares. Gam Ag holds 0.56% or 779,436 shares. Invesco holds 2.79 million shares. Buckingham, a Alabama-based fund reported 36,786 shares. The institutional investor held 35,746 shares of the industrial machinery and components company at the end of 2017Q2, valued at $2.38 million, up from 24,211 at the end of the previous reported quarter. Asset Advsr reported 107,415 shares. Da Davidson has 140,666 shares. Twin owns 91,250 shares or 0.26% of their U.S. portfolio. The ex-dividend date is Wednesday, January 11th.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER